AlzeCure Pharma (Sweden) Price on November 12, 2024
ALZCUR Stock | SEK 1.19 0.16 15.53% |
If you're considering investing in AlzeCure Stock, it is important to understand the factors that can impact its price. As of today, the current price of AlzeCure Pharma stands at 1.19, as last reported on the 30th of November, with the highest price reaching 1.20 and the lowest price hitting 1.04 during the day. AlzeCure Pharma secures Sharpe Ratio (or Efficiency) of -0.16, which signifies that the company had a -0.16% return per unit of risk over the last 3 months. AlzeCure Pharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm AlzeCure Pharma's Standard Deviation of 4.28, mean deviation of 3.04, and Risk Adjusted Performance of (0.13) to double-check the risk estimate we provide.
AlzeCure Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
AlzeCure |
Sharpe Ratio = -0.1618
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | ALZCUR |
Estimated Market Risk
4.25 actual daily | 37 63% of assets are more volatile |
Expected Return
-0.69 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average AlzeCure Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AlzeCure Pharma by adding AlzeCure Pharma to a well-diversified portfolio.
AlzeCure Pharma Valuation on November 12, 2024
It is possible to determine the worth of AlzeCure Pharma on a given historical date. On November 12, 2024 AlzeCure was worth 1.65 at the beginning of the trading date compared to the closed value of 1.64. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of AlzeCure Pharma stock. Still, in general, we apply an absolute valuation method to find AlzeCure Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of AlzeCure Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against AlzeCure Pharma's related companies.
Open | High | Low | Close | Volume | |
1.53 | 1.65 | 1.53 | 1.62 | 44,298 | |
11/12/2024 | 1.65 | 1.65 | 1.54 | 1.64 | 7,258 |
1.60 | 1.65 | 1.55 | 1.55 | 18,575 |
Backtest AlzeCure Pharma | | | AlzeCure Pharma History | | | AlzeCure Pharma Valuation | Previous | Next |
AlzeCure Pharma Trading Date Momentum on November 12, 2024
On November 13 2024 AlzeCure Pharma was traded for 1.55 at the closing time. The highest price during the trading period was 1.65 and the lowest recorded bid was listed for 1.55 . The volume for the day was 18.6 K. This history from November 13, 2024 contributed to the next trading day price decline. The overall trading delta to the next closing price was 5.49% . The overall trading delta to the current price is 38.41% . |
AlzeCure Pharma Fundamentals Correlations and Trends
By evaluating AlzeCure Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among AlzeCure Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. AlzeCure financial account trend analysis is a perfect complement when working with valuation or volatility modules.About AlzeCure Pharma Stock history
AlzeCure Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for AlzeCure is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in AlzeCure Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing AlzeCure Pharma stock prices may prove useful in developing a viable investing in AlzeCure Pharma
AlzeCure Pharma AB develops therapies for the treatment of Alzheimer s disease and related neurodegenerative disorders. The company was founded in 2012 and is based in Huddinge, Sweden. AlzeCure Pharma is traded on Stockholm Stock Exchange in Sweden.
AlzeCure Pharma Stock Technical Analysis
AlzeCure Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
AlzeCure Pharma Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
AlzeCure Pharma cannot be verified against its exchange. Please verify the symbol is currently traded on Stockholm Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
AlzeCure Pharma November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how AlzeCure Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AlzeCure Pharma shares will generate the highest return on investment. By undertsting and applying AlzeCure Pharma stock market strength indicators, traders can identify AlzeCure Pharma entry and exit signals to maximize returns
AlzeCure Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for AlzeCure Pharma's price direction in advance. Along with the technical and fundamental analysis of AlzeCure Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of AlzeCure to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.13) | |||
Jensen Alpha | (0.90) | |||
Total Risk Alpha | (1.49) | |||
Treynor Ratio | (0.82) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for AlzeCure Stock analysis
When running AlzeCure Pharma's price analysis, check to measure AlzeCure Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AlzeCure Pharma is operating at the current time. Most of AlzeCure Pharma's value examination focuses on studying past and present price action to predict the probability of AlzeCure Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AlzeCure Pharma's price. Additionally, you may evaluate how the addition of AlzeCure Pharma to your portfolios can decrease your overall portfolio volatility.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
CEOs Directory Screen CEOs from public companies around the world | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |